Solupharm is a finished-dose manufacturer. It appears in 2 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC) and NPRA (MY).
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 1 | None |
| NPRA (MY) | 1 | None |
Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.
Choose your molecules and target markets. Solupharm comes back tiered against every other supplier able to file there.
Start for free